Article History
Received: 11 March 2024
Accepted: 29 April 2024
First Online: 14 May 2024
Declarations
:
: Sanjay Kalra is an Editorial Board member of Diabetes Therapy. Sanjay Kalra was neither involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Sanjay Kalra and Saptarshi Bhattacharya have received speaker fees from Novo Nordisk. Nitin Kapoor has nothing to disclose.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.